Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
5-Azacytidine in Elderly or Frail AML Patients
NCT00739388Phase 2Completed
- Sponsor
- Swiss Group for Clinical Cancer Research
- Start
- Jul 2008
- Primary completion
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of azacitidine in acute myeloid leukemia (AML), sponsored by Swiss Group for Clinical Cancer Research. Started Jul 2008; status: completed.
02
Drugs
azacitidine
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT00739388.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00739388.